glp-1 migraines drug could offer relief to migraine sufferers GLP-1 diabetes drugs like Ozempic

doi: 10.3389/fimmu.2022.1104462

People Taking Orforglipron Saw Substantial Reductions in Weight and A1C Levels In a 40-week placebo-controlled trial, people with type 2 diabetes taking the highest dose of orforglipron lost 16 pounds on average, or about 7.9 percent of their body weight, and were still losing weight when the study ended

Evaluating routine blood tests according to clinical symptoms and diagnostic criteria in individuals with myalgic encephalomyelitis/chronic fatigue syndrome

[11] Injection site reactions are also possible

W.FalkowskiN

Knowledge of immunometabolism is constantly evolving, and glutamine metabolism may be a potential therapeutic target for autoimmune disease therapy